RamSoft and Therapixel have entered into a commercial partnership.
Under the agreement, RamSoft will integrate Therapixel’s MammoScreen into RamSoft’s PowerServer and OmegaAI platforms.
In a statement, RamSoft noted three AI-driven capabilities of MammoScreen:
- Precheck to review image quality and key patient information prior to reading.
- Analysis for detecting and characterizing lesions, also incorporating previous imaging and a breast density assessment.
- Prereporting that populates structured results into existing reporting systems.
RamSoft also highlighted clinical study results that showed how the software, using 2D, 3D, and prior images, demonstrated measurable improvements in radiologist performance: an 8% increase in sensitivity, a 2% boost in specificity, and average reading and reporting time reductions of 24%, according to the firm.
